Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
Titel:
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
Auteur:
Katopodis, O. Souglakos, J. Stathopoulos, E. Christopoulou, A. Kontopodis, E. Kotsakis, A. Kalbakis, K. Kentepozidis, N. Polyzos, A. Hatzidaki, D. Georgoulias, V.